Brief: RTW Biotech Opportunities Reports Unaudited NAV As At 31 March 2025 At $1.69 Per Share
14/04/2025 07:30
April 14 (Reuters) - RTW Biotech Opportunities Ltd RTW.L: RTW BIOTECH OPPORTUNITIES LTD - UNAUDITED NAV AS AT 31 MARCH 2025 AT $1.69 PER SHARE, DOWN 5.5% FROM FEBRUARY RTW BIOTECH OPPORTUNITIES: IN RESPONSE TO CHANGING POLITICAL ENVIRONMENT, RTW HAS CREATED A NEW GOVERNMENT AFFAIRS TEAM RTW BIOTECH OPPORTUNITIES: AFTER QUARTER END, TRUMP'S INITIATION OF A GLOBAL TRADE WAR PRECIPITATED A FURTHER DRAMATIC EQUITY SELL-OFF Source text: ID:nRSN7782Ea Further company coverage: RTW.L ((Reuters.Briefs@thomsonreuters.com;))